31

Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Embed Size (px)

Citation preview

Page 1: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university
Page 2: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Cardiovascular Pharmacology

Professor Doctor: Abd Al Rahman Abd Al Fattah

YassinProfessor and head of clinical pharmacology

departmentMansura university

Page 3: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

DRUG THERAPY OF

ANGINA PECTORIS

Page 4: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Definition• It is a clinical syndrome characterized

by sudden severe pressing sub sternal pain that often radiate to the left shoulder and along the flexor surface of the left arm that occurs when coronary blood flow is inadequate to supply the oxygen required by the heart.

Page 5: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

• Angina occurs when the myocardial oxygen demands exceed the oxygen requirement.

Page 6: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Types of Angina• Stable angina: (Effort, typical angina): The

pain is commonly induced by exercise, emotion or heavy meals.

• Variant angina: (Prinzmetal's angina, -receptor–mediated vasoconstriction): Patient develope pain even at rest.

• Unstable angina: (accelerated angina): There is a change in pattern, increase in frequency, severity and/or duration of pain.

Page 7: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Treatment of Angina Pectoris Includes:

• A. General Measures

• Alteration of life style: avoid intolerable

effort, stress, heavy meals, and smoking.

• Correct obesity and reduce fat intake.

• Treatment of predisposing factors e.g.

hyperlipidemia, hypertension, heart failure,

arrhythmias, anemia and diabetes mellitus.

Page 8: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

B. Drugs• Drugs used during the acute attack:• nitrites or nitrates.• Sedative, analgesics and tranquilizers . • Drugs used in between the attacks:• Long acting nitrates.• Beta adrenoceptor blockers.• Calcium channel blockers.• Cytoprotective drugs(trimetazidine,ranolazine)• Antiplatelets:aspirin,clopidogril.• statins.• C. Surgical Treatment: (Myocardial revascularization)

Page 9: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

NITRITES AND NITRATES

Organic nitrates are ester of nitric acid whereas

organic nitrites are esters of nitrous acid.They

are potent vasodilators.

Page 10: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Pharmacologic Characteristics of Currently Available Nitrates

Page 11: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Pharmacokineticsa• It is absorbed through mucous membrane,

gastrointestinal tract, skin and from tracheobronchial tree by inhalation.

• Sublingual administration produces rapid onset (2-5 minutes) and short duration (less than 30 minutes)

• It is metabolized by the liver. • Oral preparations provide more prolonged

prophylaxis.• Excretion of nitrates is largely via the kidney.

Page 12: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Mechanism of action

Nitrates converted to NO(nitric oxide) which increase

cGMP,which cause

V.D of vein more than artery.

SH group is required for this conversion.

Page 13: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Pharmacological Effects• Cardiovascular system• Blood vessels• Nitrites are dilators of venous and to less extent arterial

smooth muscle.• They increase coronary blood flow due to coronary

vasodilatation • Arteriolar dilatation of the face and neck lead to flushing • Vasodilatation of the meningeal arteries leads to throbbing

headache. • Heart• The effects on the heart are secondary to the peripheral

effects. They produce tachycardia, decreased venous return and so the cardiac output (COP) and cardiac work are decreased.

Page 14: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Blood pressure• Rapid administration of high doses decreases

systolic and diastolic blood pressure and COP resulting in palpitations, weakness, dizziness and tachycardia.

• Systemic venous capacity is increased due to venular dilatation and this reduces both the venous return and the pulmonary pressure.

Page 15: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Pharmacolgical effect• Action on smooth muscle: They relax biliary,

G.I.T,bronchial and uterine smooth muscles.• Action on respiration

• Reflex increase in the respiratory rate through the carotid body or secondary to hypotension.

• Smooth muscle relaxation in bronchospastic disorders.

• Action on blood: Nitrate ions readily oxidize to methaemoglobin.

Page 16: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Therapeutic Uses• 1. Angina pectoris• Nitrates are effective in the different types of angina: • • [A] Reduction of myocardial oxygen demand via:• Venodilatation leading to decreased preload.• Arteriodilatation leading to decreased afterload.• [B] Enhancement of myocardial perfusion• Through:• Coronary vasodilatation• Redistribution of coronary flow to the ischaemic subendocardium

Page 17: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

.

• 2. Congestive heart failure: Due to: mainly reduction of pre-load.

• And reduction of afterload.• 3. Acute myocardial infarction:

Nitroglycerine (NG) may reduce the area of myocardial damage and may preserve viable tissues.

• 4. Other uses • Biliary colic.• Management of constriction ring of uterus.• Treatment of cyanide.poisoning.

Page 18: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Adverse Reactions

• Throbbing headache.

• Postural hypotension, dizziness and even syncope.

• Tachycardia and palpitations.

• Flushing in the face.

• Methaemoglobinaemia.

• Tolerance especially during chronic exposure.

Page 19: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Precautions• Start with the smallest possible dose in order to

minimise side effects.• Nitrate therapy should not abruptly stop to avoid

withdrawal symptoms.• The patient should consult his doctor when more

than 3 tablets sublingually taken over 15 minutes without improvement for fear of MI.

• Nitroglycerine tablets should not be put in sunlight, or with cotton.

• The expiry date should be checked (active tablets have burning taste).

Page 20: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

CALCIUM CHANNEL BLOCKERS (CCBs)

• pharmacologyThe of (CCBs) was discussed before. They are effective in the management of variant angina, chronic stable angina and in some subsets of unstable angina. What are the underlying mechanisms of CCBs in angina?

Page 21: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

BETA BLOCKERS• Beta-blockers are useful in the

management of stable and unstable angina. However, they may worsen variant angina due coronary spasm. Sudden cessation of -blockers may worse the angina due to up regulation of -receptors. The beneficial effects of beta-blockers in angina are:

Page 22: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Mechanism of action of beta blockers as an anti ischemic:

• They slow the heart rate.

• .They decrease force of cardiac contraction.

• Beta blockers may exert cytoprotective effect.

• Combined use of beta-blockers and nitrates are very effective

in the treatment of typical angina.why

• Because some of the negative aspects of the effects of each

drug are reduced.

• For example, the reflex tachycardia and increased

contractility induced by nitrates are blocked by B-blockers.

Page 23: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Effects of - blockers, nitrates and their combinations in therapy of angina

Page 24: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

CYTOPROTECTIVE AGENTS• This cytoprotection is obtained by providing enough

energy to maintain an efficient myocardial contraction during ischemia e.g. TRIMETAZIDINE:

• It produces a metabolic switch via inhibition of fatty acid oxidation toward activation of glucose oxidation during ischemia

• It preserves contractile function and limit cytolysis.• It limits membrane damage induced by oxygen free

radical

Page 25: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Anti-platelete drugs:

• Aspirin small dose. Ticlopidine-clopidogre. Abciximab-tirofiban

Page 26: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Other antianginal drugs:

Nicorandil

ranolazine

Page 27: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Selection of Anti anginal drugs for patients with angina pectoris and concomitant diseases

Page 28: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

Beneficial anti anginal combinations

• Nitrate plus beta blockers• Nitrate plus verapamil

• Unfavorable antianginal combinations• Nitrate plus nifidipine.• Beta blocker plus verapamil.

Page 29: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

DRUG THERAPY OF ACUTE MYOCARDIAL INFARCTION (AMI)

• Myocardial infarction is coagulative necrosis of a part of the cardiac muscles as a result of sudden and persistent cessation of its blood supply.

• All patients should be admitted to the coronary care unit..

Page 30: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

DRUG THERAPY OF A. M.I• Oxygen: To increase PO2.• Relief of pain: Morphine sulfate or Mepridine. • Sedation: by diazepam • Measures to limit the size of infarction: Beta-

blockers, NG or CCBs

Page 31: Cardiovascular Pharmacology Professor Doctor: Abd Al Rahman Abd Al Fattah Yassin Professor and head of clinical pharmacology department Mansura university

DRUG THERPY OF A.M.I.• Fibrinolytic therapy: e.g. Streptokinase• Anticoagulants• Treatment of arrhythmias, heart failure and

cardiogenic shock: • Control of risk factors: Stop smoking; physical

activity, control hypertension, obesity, diabetes mellitus and correction of plasma lipids.